Ms. Cheng Cheung Ling
Executive Vice Chairlady
chemical
Sino Biopharmaceutical Ltd
China
Biography
Ms. Cheng Cheung Ling serves as Executive Vice Chairlady of the Board of Sino Biopharmaceutical Ltd. She was appointed as an executive director, the Vice Chairlady of the Board, and a member of the Executive Board Committee of the Company on 10 April, 2017. Ms. Cheng graduated from the Guanghua School of Management of Peking University and obtained a Master Degree in Business Administration. She is a clinician. Ms. Cheng has extensive experience in and a discerning vision for management and investment in the pharmaceutical industry. She spares no effort in promoting innovation and research and development capabilities in the industry. She is the chairman of Beijing Tide. As the Chairlady of Beijing Tide, Ms. Cheng advocates for product innovation and uniqueness and has led Beijing Tide to focus on research and development innovations and international collaboration, to promote rapid development of cutting-edge technologies for medical products in China, and to give top priority to quality control, regarding product quality as the lifeblood of the company. Under her leadership, Beijing Tide has achieved tremendous growth, riding on internationalisation and innovation. Over the years, Ms. Cheng is committed to facilitating communication and trade between Mainland China and Hong Kong, and she is also a devoted charity supporter, actively participating in and caring for community philanthropy.
Research Interest
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is engaged in long term investments. The Others segment is engaged in the provision of research and development activities and services to third parties, as well as related healthcare and hospital business. The Company is also involved in the property holding, the sales of health food, the manufacture and optometry of optical glasses, as well as the retail and wholesale of optical and auditory products through its subsidiaries.